RxDoctor Payments Data

Matthew Raymond, DO

Physical Medicine & Rehabilitation · Southington, CTNPI 1457332181

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,320 of the $3,637 with a category attached, or 91.3%. Ipsen Biopharmaceuticals, Inc accounts for 94.0% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $3,343 and has fallen 97.7% since, to $78 in 2025. Among physical medicine & rehabilitation clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,637in general payments, 2019–2025

Across 8 payments — averaging $454.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ipsen Biopharmaceuticals, Inc$3K
  • Medtronic$197
  • Piramal Critical Care$23

What the payments were for

  • Consulting fees$3,32091%
  • Food & beverage$2577%
  • Education$612%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ipsen Biopharmaceuticals, Inc4$3,418
Medtronic3$197
Piramal Critical Care1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,637 in reported general payments places this provider in the 90th percentile of 107 physical medicine & rehabilitation providers in Connecticut.

See all physical medicine & rehabilitation providers in Connecticut

Medicare billing

Part B allowed, 2024
$1,125,017
Medicare patients
245
Services billed
87,956

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DysportAbobotulinumtoxina26$49,707
Baclofen284$6,717
Tizanidine Hcl63$3,682
Pregabalin35$3,158
Gabapentin92$1,234
Duloxetine Hcl56$691
Methenamine Hippurate14$640
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$286
Amitriptyline Hcl16$193
Diazepam36$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$104
Clonazepam20$35

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ipsen Biopharmaceuticals, IncDysport$3,418$49,70726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 107 physical medicine & rehabilitation providers in Connecticut.

Other physical medicine & rehabilitation in Southington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →